MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview

Medicinova

03/11/2021 10:50

* MediciNova Inc  MNOV.OQ   MNOV.O  is expected to show no
change in quarterly revenue when it reports  results on November
3 (estimated). 
​* Refinitiv's mean analyst estimate for MediciNova Inc is for a
loss of 9 cents per share. For the same quarter last year, the
company reported a loss of 8 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for MediciNova Inc
is $14.5​, about 76.2% above​ its last closing price
of $3.45. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.09       -0.09      -0.09     Met     -3.8
 Mar. 312021   -0.08       -0.08      0.00      Beat    100
 Dec. 312020               -0.09      -0.06     Beat    36.7​
 Sep. 302020   -0.11       -0.12      -0.08     Beat    33.3
 ​​Jun.        -0.15       -0.10      -0.10     Met     0
 302020                                                 
 Mar. 312020   -0.08       -0.08      -0.06     Beat    25​
 Dec. 312019   -0.08       -0.08      -0.05     Beat    37.5
 Sep. 302019               -0.15      -0.05     Beat    66.7
 This summary was machine generated November 3 at 10:49 GMT.  All
figures in US dollars unless otherwise stated